Navigation Links
Bradmer announces 2008 fourth quarter and fiscal year operational and financial results
Date:3/31/2009

TSX: BMR

TORONTO, March 31 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc. ("Bradmer" or the "Corporation") announced its 2008 fourth quarter and fiscal year operational and financial results.

Operational Highlights

During the year ended December 31, 2008, the Company achieved the following steps for its multi-center Phase III trial of its lead drug Neuradiab(R), a treatment for glioblastoma multiforme (GBM), the most advanced form of brain cancer:

    -   Prepared and submitted the Company's drug manufacturing data package
        and clinical dossiers to the FDA;
    -   Initiated enrollment in the Phase III GLASS-ART clinical trial;
    -   Signed contracts with and activated an initial cohort of five U.S.
        clinical trial sites;
    -   Successfully released a second GMP drug substance batch for use in
        clinical trials and filed the related update with the FDA;
    -   Submitted new data from the previous Phase II trial indicating that
        the mean time to progression free survival was 77 weeks, which
        compares favorably with other published results in newly diagnosed
        GBM (Reardon et al.; 2008 Neuro-Oncology 10:845); and
    -   Sourced and validated commercial supplies of iodine-131 outside of
        the U.S. and Europe to prevent delays in raw material supply.

Subsequent to the financial year ended December 31, 2008, the Company commenced a strategic review of its operations, as more particularly described in press releases of the Company dated February 17, 2009 and March 5, 2009. Pursuant to the strategic review, the Company has closed its Phase III GLASS ART Trial to further patient enrollment due to unforeseen delays in site initiation and recruitment, the delayed ability to complete the 60 patient "run-in phase" in a timely manner, and the inability to raise further capital at this time.

The Company
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Bradmer implements cash conservation plan
2. Bradmer provides clinical trial update and announces evaluation of strategic alternatives
3. Bradmer to participate in panel presentation at RBC Capital Markets Healthcare Conference
4. Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting
5. Bradmer announces 2008 third quarter operational and financial results
6. Bradmer to present at Rodman & Renshaw Healthcare Conference
7. Bradmer receives FDA approval to proceed with Phase III clinical trial
8. Bradmer announces 2008 first quarter operational and financial results
9. Bradmer announces new additions to management team
10. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
11. Notice of Bradmer Pharmaceuticals Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... may have found a way to delay or even ... neurons with the anti-aging protein Klotho can prevent neuron ... and glutamate. These findings currently appear in the ... is the most frequent age-related dementia affecting 5.4 million ... older and more than 40 percent of people over ...
(Date:7/24/2014)... 24, 2014 This year the Walk ... Electric and Jackson National Life, will be held on Saturday, ... am, the Kids Fun Run at 7:50 am, the untimed ... 9 a.m. , “The Walk to End Alzheimer’s unites the ... in the fight against this devastating disease, “stated Linda Mitchell, ...
(Date:7/24/2014)... 24, 2014 (HealthDay News) -- Drinking caffeine may worsen ... two-thirds of women as they go through menopause, new ... our study suggests that limiting caffeine intake may be ... flashes and night sweats," said researcher Dr. Stephanie Faubion, ... Clinic in Rochester, Minn. But caffeine -- a ...
(Date:7/24/2014)... or more equally positive outcomes experience paradoxical feelings ... in different regions of the brain, according to ... scholar at the Princeton Neuroscience Institute at Princeton ... rated the desirability of more than 300 products ... images of paired products with different or similar ...
(Date:7/24/2014)... Le Bonheur Children,s Hospital and the University of Tennessee ... of a new drug shown to safely reduce the ... intranasally infected with respiratory syncytial virus (RSV). RSV is ... in young children in the United States and worldwide. ... Infectious Disease Specialist John DeVincenzo, MD. DeVincenzo,s Le Bonheur ...
Breaking Medicine News(10 mins):Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 3Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:Brain's dynamic duel underlies win-win choices 2Health News:Brain's dynamic duel underlies win-win choices 3Health News:RSV research breakthrough to help infected children 2
... with lung cancer remains to be established, a new ... Journal of Thoracic Oncology provides compelling evidence of ... Researchers at China Medical University and Hospital in Taiwan ... National Health Insurance (NHI) program. All patients aged 20 ...
... PROVIDENCE, R.I. [Brown University] A new study of ... seeking a hospice benefit and using it longer. The ... residents die with some degree of dementia. Researchers hope ... benefit even as they seek to control Medicare costs. ...
... By Dennis Thompson HealthDay Reporter , THURSDAY, ... played a big role in averting a major health crisis. ... pitch last winter, with public health officials fearing a widespread ... an epidemic was averted, and some health experts believe that,s ...
... , WEDNESDAY, Dec. 29 (HealthDay News) -- A treatment ... of patients suffering from multiple chronic illnesses such as ... in the Dec. 30 issue of the New ... four areas of blood sugar, blood pressure, cholesterol control ...
... Reporter , WEDNESDAY, Dec. 29 (HealthDay News) -- Consider this: ... cancer in the United States, killing about 157,300 people every ... according to the U.S. National Institutes of Health. , It ... only to heart disease. And yet lung cancer ...
... , WEDNESDAY, Dec. 29 (HealthDay News) -- People generally ... those of others, according to a new study. ... to 11 people. Each person talked with every other ... rated the other person,s physical attractiveness and five major ...
Cached Medicine News:Health News:Study finds evidence of increased lung cancer risk among tuberculosis patients 2Health News:Hospice care increasing for nursing home patients with dementia 2Health News:Hospice care increasing for nursing home patients with dementia 3Health News:Hand-Washing May Have Kept Flu at Bay 2Health News:Hand-Washing May Have Kept Flu at Bay 3Health News:Team-Based Treatment Helps Those With Cluster of Chronic Illnesses 2Health News:Team-Based Treatment Helps Those With Cluster of Chronic Illnesses 3Health News:Deadliest Cancer Getting Smaller Chunk of Research Dollars 2Health News:Deadliest Cancer Getting Smaller Chunk of Research Dollars 3Health News:Deadliest Cancer Getting Smaller Chunk of Research Dollars 4
(Date:7/24/2014)... WASHINGTON , July 24, 2014  The ... Brightree is supporting its mission to help address ... new and exclusive agreement to be the information ... service. As the leading provider of billing and ... brings unmatched HME industry expertise to support this ...
(Date:7/24/2014)... , July 24, 2014 Consolidated Net ... Business Highlights   , India Business grew ... by 9.33% to Rs. 4,886.70 Mn Rest of World ... Europe Formulations Business grew by 34.53% to Rs. 977.26 Mn ... , Glenmark Pharmaceuticals Limited, the research-led global ...
(Date:7/24/2014)... July 24, 2014 /PRNewswire-iReach/ -- "North America Orthopedic Braces ... data on the North America Orthopedic Braces and Supports ... dollars, and volume (in units) and average price data ... Knee Braces and Supports , Ankle Braces and ... Upper Extremities Braces and Supports. ...
Breaking Medicine Technology:Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5
... 8, 2011 The U.S. Food and Drug Administration today launched ... the safe disposal of needles and other so-called "sharps" that ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The website will ... disposing of used sharps and how users should safely dispose ...
... Nov. 8, 2011 Dengue v2V, a group of international ... in Puerto Rico on 5–6 November 2011 to continue to ... licensed. Dengue is a threat to almost half of the ... and Asia where epidemics are common.(1) "Puerto ...
Cached Medicine Technology:FDA Launches Website on Safe Disposal of Used Needles and Other "Sharps" 2FDA Launches Website on Safe Disposal of Used Needles and Other "Sharps" 3FDA Launches Website on Safe Disposal of Used Needles and Other "Sharps" 4International Experts Outline Public Health Initiatives for Future Dengue Vaccine Introduction and Control of Dengue Fever 2International Experts Outline Public Health Initiatives for Future Dengue Vaccine Introduction and Control of Dengue Fever 3
... Ethisorb Dura Patch is a synthetic absorbable ... and. spinalis defects. Ethisorb Dura Patch is pliable, ... cut to the desired shape, care must be ... violet dyed, PDS foil covered side is oriented ...
... More than a patch, Duragen is ... dura mater. Duragen handles and conforms ... an innovative collagen matrix for dural ... repair of dural defects. Fully resorbed ...
Elmed electrosurgical systems for major surgery....
Aaron 1250 is a multipurpose electrosurgical generator with monopolar and bi-polar functions....
Medicine Products: